Noriko Gotoh
University of Tokyo
Institute of Medical Science
Division of Systems Biomedical Technology
4-6-1 Shirokanedai
Japan
Name/email consistency: high
- Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer. Nakata, A., Gotoh, N. Expert Opin. Ther. Targets (2012)
- Feedback inhibitors of the epidermal growth factor receptor signaling pathways. Gotoh, N. Int. J. Biochem. Cell Biol. (2009)
- The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment. Sato, T., Gotoh, N. Expert Opin. Ther. Targets (2009)
- Control of stemness by fibroblast growth factor signaling in stem cells and cancer stem cells. Gotoh, N. Curr. Stem. Cell. Res. Ther (2009)
- Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Gotoh, N. Cancer Sci. (2008)
- FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts. Gotoh, N., Laks, S., Nakashima, M., Lax, I., Schlessinger, J. FEBS Lett. (2004)